A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

This study has been completed.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			HIV Infections
2		Additional conditions recognized in this trial
			Acquired Immunodeficiency Syndrome
			Communicable Diseases
			Infection
3		More general conditions related to this trial
			Immune System Diseases
			Immunologic Deficiency Syndromes
			Lentivirus Infections
			Retroviridae Infections
			RNA Virus Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Viral
			Slow Virus Diseases
			Virus Diseases
4		Interventions listed in this trial
			Indinavir sulfate
			Lamivudine/Zidovudine
			Ritonavir
			Hydroxyurea
			Abacavir sulfate
			Amprenavir
			Nelfinavir mesylate
			Efavirenz
			Lamivudine
			Stavudine
			Zidovudine
			Didanosine
5		Additional drug interventions recognized in this trial
			Abacavir
			Indinavir
			Nelfinavir
6		More general drug interventions related to this trial
			Anti-Bacterial Agents
			Anti-HIV Agents
			Anti-Infective Agents
			Anti-Retroviral Agents
			Antibiotics, Antitubercular
			Antimetabolites
			Antineoplastic Agents
			Antisickling Agents
			Antitubercular Agents
			Antiviral Agents
			Enzyme Inhibitors
			Hematologic Agents
			HIV Protease Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Protease Inhibitors
			Reverse Transcriptase Inhibitors
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Allergy and Infectious Diseases (NIAID)